RODIGARI, LARA
RODIGARI, LARA
Mostra
records
Risultati 1 - 3 di 3 (tempo di esecuzione: 0.009 secondi).
High rate of profound clonal and renal responses with daratumumab treatment in heavily pre-treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltrate
2020-01-01 Milani, P.; Fazio, F.; Basset, M.; Berno, T.; Larocca, A.; Foli, A.; Riva, M.; Benigna, F.; Oliva, S.; Nuvolone, M.; Rodigari, L.; Petrucci, M. T.; Merlini, G.; Palladini, G.
Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy
2020-01-01 Milani, P.; Basset, M.; Nuvolone, M.; Benigna, F.; Rodigari, L.; Lavatelli, F.; Foli, A.; Merlini, G.; Palladini, G.
Sequential response-driven bortezomib-based therapy followed by autologous stem cell transplant in AL amyloidosis
2020-01-01 Basset, Marco; Milani, Paolo; Nuvolone, Mario; Benigna, Francesca; Rodigari, Lara; Foli, Andrea; Merlini, Giampaolo; Palladini, Giovanni
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| High rate of profound clonal and renal responses with daratumumab treatment in heavily pre-treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltrate | 1-gen-2020 | Milani, P.; Fazio, F.; Basset, M.; Berno, T.; Larocca, A.; Foli, A.; Riva, M.; Benigna, F.; Oliva, S.; Nuvolone, M.; Rodigari, L.; Petrucci, M. T.; Merlini, G.; Palladini, G. | |
| Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy | 1-gen-2020 | Milani, P.; Basset, M.; Nuvolone, M.; Benigna, F.; Rodigari, L.; Lavatelli, F.; Foli, A.; Merlini, G.; Palladini, G. | |
| Sequential response-driven bortezomib-based therapy followed by autologous stem cell transplant in AL amyloidosis | 1-gen-2020 | Basset, Marco; Milani, Paolo; Nuvolone, Mario; Benigna, Francesca; Rodigari, Lara; Foli, Andrea; Merlini, Giampaolo; Palladini, Giovanni |